Rockville biotech tests stem cells for depression

Monday, July 2, 2012 By: Gazette staff Neuralstem, the Rockville company that's developing a stem cell treatment for patients with amyotrophic lateral sclerosis, has begun testing the safety of its treatment for major depressive disorder. The compound, NSI-189, stimulates new neuron growth in the brain's hippocampus region, which scientists think is involved in depression and